Results for 'HER2'

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Feb 23rd • 8 mins read

Loose Regulatory Standards Portend a New Era of Imprecision Oncology
Dec 1st • 4 mins read

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
Nov 20th • 12 mins read

Leveraging existing data to contextualize phase II clinical trial findings in oncology
Sep 21st • 3 mins read